Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Schotsaert and Adolfo García-Sastre.
Michael Schotsaert
Connection Strength
2.546
Adolfo García-Sastre
  1. Inactivated influenza virus vaccines: the future of TIV and QIV. Curr Opin Virol. 2017 04; 23:102-106.
    View in: PubMed
    Score: 0.716
  2. Corrigendum: Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine. Angew Chem Int Ed Engl. 2021 Jul 26; 60(31):16741-16742.
    View in: PubMed
    Score: 0.240
  3. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021 Jul; 2(7):e283-e284.
    View in: PubMed
    Score: 0.235
  4. Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*. Angew Chem Int Ed Engl. 2021 04 19; 60(17):9467-9473.
    View in: PubMed
    Score: 0.233
  5. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science. 2021 02 26; 371(6532):926-931.
    View in: PubMed
    Score: 0.231
  6. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc Natl Acad Sci U S A. 2020 11 10; 117(45):28344-28354.
    View in: PubMed
    Score: 0.227
  7. Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2. Science. 2021 07 30; 373(6554):541-547.
    View in: PubMed
    Score: 0.060
  8. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression. Hum Pathol. 2021 08; 114:110-119.
    View in: PubMed
    Score: 0.059
  9. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol. 2021 08; 34(8):1456-1467.
    View in: PubMed
    Score: 0.059
  10. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell. 2021 05 13; 184(10):2618-2632.e17.
    View in: PubMed
    Score: 0.059
  11. Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model. mBio. 2021 03 02; 12(2).
    View in: PubMed
    Score: 0.058
  12. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg Microbes Infect. 2020 Dec; 9(1):2433-2445.
    View in: PubMed
    Score: 0.057
  13. Animal models for COVID-19. Nature. 2020 10; 586(7830):509-515.
    View in: PubMed
    Score: 0.057
  14. Current Status of COVID-19 (Pre)Clinical Vaccine Development. Angew Chem Int Ed Engl. 2020 10 19; 59(43):18885-18897.
    View in: PubMed
    Score: 0.056
  15. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020 10; 586(7827):113-119.
    View in: PubMed
    Score: 0.056
  16. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines (Basel). 2018 Sep 14; 6(3).
    View in: PubMed
    Score: 0.049
  17. Spatial-Temporal Lineage Restrictions of Embryonic p63+ Progenitors Establish Distinct Stem Cell Pools in Adult Airways. Dev Cell. 2018 03 26; 44(6):752-761.e4.
    View in: PubMed
    Score: 0.048
  18. Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death. Nat Commun. 2017 12 05; 8(1):1931.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.